Free Trial
NASDAQ:IRMD

iRadimed (IRMD) Stock Price, News & Analysis

iRadimed logo
$57.57 -1.90 (-3.19%)
Closing price 07/11/2025 04:00 PM Eastern
Extended Trading
$57.60 +0.03 (+0.06%)
As of 07/11/2025 04:04 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

About iRadimed Stock (NASDAQ:IRMD)

Key Stats

Today's Range
$57.52
$59.47
50-Day Range
$51.01
$61.83
52-Week Range
$42.34
$63.29
Volume
36,837 shs
Average Volume
44,238 shs
Market Capitalization
$732.29 million
P/E Ratio
37.14
Dividend Yield
1.18%
Price Target
$72.00
Consensus Rating
Buy

Company Overview

iRadimed Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
98th Percentile Overall Score

IRMD MarketRank™: 

iRadimed scored higher than 98% of companies evaluated by MarketBeat, and ranked 28th out of 938 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    iRadimed has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 1 buy rating, no hold ratings, and no sell ratings.

  • Amount of Analyst Coverage

    iRadimed has received no research coverage in the past 90 days.

  • Read more about iRadimed's stock forecast and price target.
  • Earnings Growth

    Earnings for iRadimed are expected to grow by 20.48% in the coming year, from $1.66 to $2.00 per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of iRadimed is 37.14, which means that it is trading at a more expensive P/E ratio than the market average P/E ratio of about 25.85.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of iRadimed is 37.14, which means that it is trading at a more expensive P/E ratio than the Medical sector average P/E ratio of about 28.26.

  • Price to Book Value per Share Ratio

    iRadimed has a P/B Ratio of 8.40. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

  • Read more about iRadimed's valuation and earnings.
  • Percentage of Shares Shorted

    2.88% of the float of iRadimed has been sold short.
  • Short Interest Ratio / Days to Cover

    iRadimed has a short interest ratio ("days to cover") of 4.9.
  • Change versus previous month

    Short interest in iRadimed has recently decreased by 3.02%, indicating that investor sentiment is improving.
  • Dividend Yield

    iRadimed pays a meaningful dividend of 1.18%, higher than the bottom 25% of all stocks that pay dividends.

  • Dividend Growth

    iRadimed has only been increasing its dividend for 1 years.

  • Dividend Coverage

    The dividend payout ratio of iRadimed is 43.87%. This payout ratio is at a healthy, sustainable level, below 75%.

  • Dividend Sustainability

    Based on earnings estimates, iRadimed will have a dividend payout ratio of 34.00% next year. This indicates that iRadimed will be able to sustain or increase its dividend.

  • Read more about iRadimed's dividend.
  • Percentage of Shares Shorted

    2.88% of the float of iRadimed has been sold short.
  • Short Interest Ratio / Days to Cover

    iRadimed has a short interest ratio ("days to cover") of 4.9.
  • Change versus previous month

    Short interest in iRadimed has recently decreased by 3.02%, indicating that investor sentiment is improving.
  • News Sentiment

    iRadimed has a news sentiment score of 1.28. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.99 average news sentiment score of Medical companies.
  • News Coverage This Week

    MarketBeat has tracked 2 news articles for iRadimed this week, compared to 3 articles on an average week.
  • Insider Buying vs. Insider Selling

    In the past three months, iRadimed insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    36.80% of the stock of iRadimed is held by insiders. A high percentage of insider ownership can be a sign of company health.

  • Percentage Held by Institutions

    92.34% of the stock of iRadimed is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

  • Read more about iRadimed's insider trading history.
Receive IRMD Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for iRadimed and its competitors with MarketBeat's FREE daily newsletter.

IRMD Stock News Headlines

"I'm risking my reputation on this"
Behind closed doors, away from the mainstream media's eyes, the smartest minds in crypto are all seeing the same signals. They're positioning themselves for something unprecedented. And after 17 million podcast downloads and over 600 insider interviews, I finally connected all the dots… What I discovered was so explosive, so potentially life-changing, that I had to put it all in a book.
Iradimed Corp Bottom Line Rises In Q1
Iradimed Announces Quarterly Results
See More Headlines

IRMD Stock Analysis - Frequently Asked Questions

iRadimed's stock was trading at $55.00 on January 1st, 2025. Since then, IRMD stock has increased by 4.7% and is now trading at $57.57.

iRadimed Corporation (NASDAQ:IRMD) announced its quarterly earnings data on Thursday, February, 13th. The medical equipment provider reported $0.40 EPS for the quarter, missing analysts' consensus estimates of $0.45 by $0.05. The medical equipment provider earned $19.39 million during the quarter, compared to analyst estimates of $19.09 million. iRadimed had a net margin of 26.33% and a trailing twelve-month return on equity of 23.28%.
Read the conference call transcript
.

Shares of IRMD stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that iRadimed investors own include NVIDIA (NVDA), Meta Platforms (META), Advanced Micro Devices (AMD), Tesla (TSLA), Netflix (NFLX), Broadcom (AVGO) and Alphabet (GOOG).

Company Calendar

Last Earnings
2/13/2025
Record date for 5/30 Dividend
5/20/2025
Ex-Dividend for 5/30 Dividend
5/20/2025
Dividend Payable
5/30/2025
Today
7/13/2025
Next Earnings (Estimated)
7/30/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
MED INSTRUMENTS
Sub-Industry
Medical Equipment
Current Symbol
NASDAQ:IRMD
CIK
1325618
Employees
110
Year Founded
N/A

Price Target and Rating

High Price Target
$72.00
Low Price Target
$72.00
Potential Upside/Downside
+25.1%
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
1 Analysts

Profitability

EPS (Trailing Twelve Months)
$1.55
Trailing P/E Ratio
37.14
Forward P/E Ratio
34.68
P/E Growth
N/A
Net Income
$19.23 million
Net Margins
26.33%
Pretax Margin
33.23%
Return on Equity
23.28%
Return on Assets
20.59%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
8.87
Quick Ratio
7.62

Sales & Book Value

Annual Sales
$73.24 million
Price / Sales
10.00
Cash Flow
$1.58 per share
Price / Cash Flow
36.39
Book Value
$6.85 per share
Price / Book
8.40

Miscellaneous

Outstanding Shares
12,720,000
Free Float
8,036,000
Market Cap
$732.29 million
Optionable
Optionable
Beta
0.91

Social Links

Ten Starter Stocks For Beginners to Buy Now Cover

Just getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.

Get This Free Report

This page (NASDAQ:IRMD) was last updated on 7/13/2025 by MarketBeat.com Staff
From Our Partners